153 related articles for article (PubMed ID: 33248173)
1. Vedolizumab-induced cholestatic liver injury.
Rojas-Feria M; Rodríguez-Fernández M; Castro-Fernández M; Suárez-García E
Gastroenterol Hepatol; 2022 Jan; 45(1):64-65. PubMed ID: 33248173
[No Abstract] [Full Text] [Related]
2. [Acute cholestatic hepatitis caused by simvastatine in a 67-year-old patient].
Lata S; Chudy B
Przegl Lek; 2006; 63 Suppl 7():97-8. PubMed ID: 17806197
[TBL] [Abstract][Full Text] [Related]
3. Acute Pancreatitis in a Patient With Ulcerative Colitis on Vedolizumab.
Lin E; Katz S
Inflamm Bowel Dis; 2020 Apr; 26(5):e44. PubMed ID: 32100867
[No Abstract] [Full Text] [Related]
4. Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis.
de Freitas LF; Feitosa MR; Féres O; Parra RS
Inflamm Bowel Dis; 2021 Jan; 27(2):e15-e17. PubMed ID: 33048114
[No Abstract] [Full Text] [Related]
5. Acneiform eruption induced by vedolizumab.
Magdaleno-Tapial J; Ferrer-Guillén B; Valenzuela-Oñate C; Esteve-Martínez A
Dermatol Online J; 2018 Oct; 24(10):. PubMed ID: 30677821
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis Induced by Vedolizumab.
Sody E; Körber A
Inflamm Bowel Dis; 2017 Feb; 23(2):E9-E11. PubMed ID: 28107281
[No Abstract] [Full Text] [Related]
7. Hidradenitis Suppurativa Caused by Vedolizumab.
Licata G; Gambardella A; De Rosa A; Calabrese G; Alfano R; Argenziano G
Dermatitis; 2021 Jan-Feb 01; 32(1):e23-e24. PubMed ID: 33208632
[No Abstract] [Full Text] [Related]
8. Vedolizumab-Associated Acute Respiratory Distress Syndrome.
Nambiar S; Karippot A; Oliver T
Am J Ther; 2018; 25(5):e592-e593. PubMed ID: 29189313
[No Abstract] [Full Text] [Related]
9. Vedolizumab-induced acne in inflammatory bowel disease.
Gilhooley E; Doherty G; Lally A
Int J Dermatol; 2018 Jun; 57(6):752-753. PubMed ID: 29654701
[No Abstract] [Full Text] [Related]
10. Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.
McLean LP; Cross RK
Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):833-42. PubMed ID: 27096357
[TBL] [Abstract][Full Text] [Related]
11. Vedolizumab-induced acute interstitial lung injury in a 39-year-old male with ulcerative colitis.
Rizos ED; Antonogiannaki EM; Chatzidakis A; Kallieri M; Tsilogianni Z; Manali ED; Economopoulos N; Triantafyllou K; Papiris SA; Polymeros D
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1057-e1059. PubMed ID: 34074983
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.
Pellet G; Stefanescu C; Carbonnel F; Peyrin-Biroulet L; Roblin X; Allimant C; Nachury M; Nancey S; Filippi J; Altwegg R; Brixi H; Fotsing G; de Rosamel L; Shili S; Laharie D;
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):494-501. PubMed ID: 30213584
[TBL] [Abstract][Full Text] [Related]
13. Vedolizumab-induced acute pancreatitis: the first reported clinical case.
Picardo S; So K; Venugopal K; Chin M
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29305366
[TBL] [Abstract][Full Text] [Related]
14. Severe erosive gingivostomatitis in a patient treated by vedolizumab.
Semeria L; Dadban A; Brazier F; Fumery M; Ikoli JF; Arnault JP; Adas A; Dairi M; Lok C; Chaby G
Dermatol Online J; 2020 Oct; 26(10):. PubMed ID: 33147674
[TBL] [Abstract][Full Text] [Related]
15. Erythromycin-associated cholestatic hepatitis and liver dysfunction in children: the British experience.
Karthik SV; Casson D
J Clin Gastroenterol; 2005 Sep; 39(8):743-4. PubMed ID: 16082288
[No Abstract] [Full Text] [Related]
16. Excipient Exception: A Complication of Infliximab and Vedolizumab Infusions for Ulcerative Colitis.
Dalal RS; Goksel B; Hamilton MJ
Dig Dis Sci; 2023 May; 68(5):1709-1713. PubMed ID: 36929242
[No Abstract] [Full Text] [Related]
17. [Acute cholestatic hepatitis due to chlorambucil].
Pichon N; Debette-Gratien M; Cessot F; Paraf F; Labrousse F; Sautereau D; Pillegand B
Gastroenterol Clin Biol; 2001 Feb; 25(2):202-3. PubMed ID: 11319447
[No Abstract] [Full Text] [Related]
18. Vedolizumab-Associated Pancreatitis in Paediatric Ulcerative Colitis: Functional Selectivity of the α4β7integrin and MAdCAM-1 Pathway?
Lopez RN; Gupta N; Lemberg DA
J Crohns Colitis; 2018 Mar; 12(4):507-508. PubMed ID: 29228226
[No Abstract] [Full Text] [Related]
19. [Acute cholestatic hepatitis due to glucosamine forte].
Ossendza RA; Grandval P; Chinoune F; Rocher F; Chapel F; Bernardini D
Gastroenterol Clin Biol; 2007 Apr; 31(4):449-50. PubMed ID: 17483788
[No Abstract] [Full Text] [Related]
20. The safety of vedolizumab for ulcerative colitis and Crohn's disease.
Colombel JF; Sands BE; Rutgeerts P; Sandborn W; Danese S; D'Haens G; Panaccione R; Loftus EV; Sankoh S; Fox I; Parikh A; Milch C; Abhyankar B; Feagan BG
Gut; 2017 May; 66(5):839-851. PubMed ID: 26893500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]